Immune checkpoint targeting immunotherapy has revolutionized the treatment of certain cancers in the recent years. Determination of the status of immune checkpoint expression in particular cancers may assist decision making. Here. we describe the development of a single-stranded aptamer-based molecular probe specifically recognizing human PD-L1. https://lockdownsecuritycanada.shop/product-category/remote-starter-with-interface-module/